Cirsiliol targets tyrosine kinase 2 to inhibit esophageal squamous cell carcinoma growth in vitro and in vivo

BACKGROUND: Esophageal squamous cell carcinoma (ESCC) is an aggressive and lethal cancer with a low 5 year survival rate. Identification of new therapeutic targets and its inhibitors remain essential for ESCC prevention and treatment. METHODS: TYK2 protein levels were checked by immunohistochemistry...

Full description

Saved in:

Bibliographic Details
Published in:	J Exp Clin Cancer Res
Main Authors:	Jia, Xuechao, Huang, Chuntian, Hu, Yamei, Wu, Qiong, Liu, Fangfang, Nie, Wenna, Chen, Hanyong, Li, Xiang, Dong, Zigang, Liu, Kangdong
Format:	Artigo
Language:	Inglês
Published:	BioMed Central 2021
Subjects:	Research
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC7972218/ https://ncbi.nlm.nih.gov/pubmed/33731185 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-021-01903-z
Tags:	Add Tag No Tags, Be the first to tag this record!

Cirsiliol targets tyrosine kinase 2 to inhibit esophageal squamous cell carcinoma growth in vitro and in vivo

Similar Items